MicrobeWorld App

appsquarebannerad200x200

Join MicrobeWorld

Subscribe via Email

subscribe

Microbes After Hours

MW-Site-Banner-200x200

Click for more "Microbes After Hours" videos

Featured Image

Featured Video

Crowdsourced Microbes Heading to Station

Supporters

ASM House 200X200

ICAAC 2012 - Antibody Therapies for C. difficile

Clostridium difficile infection is an important cause of intestinal disease, primarily affecting hospitalized patients exposed to antibiotics. Infection has been associated with prolonged hospital stays and excess healthcare expenditures. In recent years, C. difficile infections have become more frequent, more severe and more difficult to treat. Participants discuss one promising new treatment option, the development of human monoclonal antibodies that target either the bacterium itself or the toxin it produces.

  • Sylvia Wong, Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, ON, Canada
  • David Humphreys, UCB Pharma, Slough, United Kingdom

 

 

Comments (0)

Collections (0)

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use